Citius Oncology, Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $16.6M | $2.6M | $7.3M | $3.9M | $112 | $112 | $112 | $112 |
| Accounts Receivable | $686.2K | $1.1M | $4.0M | — | — | — | — | — |
| Inventory | $22.6M | $22.7M | $22.6M | $22.3M | $17.2M | $15.3M | $14.4M | $8.3M |
| Total Current Assets | $42.7M | $29.4M | $37.1M | $27.5M | $18.3M | $18.0M | $17.1M | $11.0M |
| Property, Plant & Equipment | — | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $112.1M | $100.7M | $110.0M | $100.9M | $91.7M | $91.4M | $90.5M | $84.4M |
| Liabilities | ||||||||
| Accounts Payable | $7.3M | $8.9M | $10.4M | $13.2M | $8.7M | $7.7M | $5.9M | $3.7M |
| Total Current Liabilities | $58.8M | $58.8M | $44.7M | $49.5M | $53.0M | $49.7M | $43.4M | $32.7M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $71.7M | $65.4M | $51.6M | $56.1M | $59.3M | $55.8M | $49.2M | $38.2M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-105.1M | $-96.2M | $-69.6M | $-64.0M | $-59.0M | $-53.7M | $-45.9M | $-39.3M |
| Total Stockholders' Equity | $40.4M | $35.3M | $58.4M | $44.9M | $32.4M | $35.6M | $41.3M | $46.1M |